Aegerion Pharmaceuticals, Inc. Bankruptcy Docket

Cases

Case closed Feb 27, 2020

Updated Oct 3, 2:08 PM ET

Petition filed
May 20, 2019
Case closed
Feb 27, 2020

Aegerion Pharmaceuticals’ Chapter 11 case was closed on February 27, 2020, under the final decree Dkt. 436. Closure followed plan confirmation on September 19, 2019, and the September 27, 2019 notice reporting plan effectiveness Dkt. 340, completing the proceeding that began in May 2019.

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Key firms

Willkie Farr & Gallagher LLPBankruptcy Counsel
Cassels Brock & Blackwell LLPBankruptcy Counsel
Herbert Smith Freehills KramerBankruptcy Counsel
Province, LLCFinancial Advisor
Moelis & CompanyInvestment Banker

Recent filings

Mar 3Post-Confirmation Report. / Post-Confirmation Affidavit of Disbursements for the Period January 1, 2020 through February 29, 2020 Filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc..Bankr. S.D.N.Y., No. 19-11632, ECF No. 438Dkt. 438
Mar 2Transcript regarding Hearing Held on 02/27/2020 At 10:06 AM RE: (Doc. No. 432) Motion For Final Decree Closing Debtors Chapter 11 Cases.; (Doc No. 426) Debtors Seventh Omnibus Objection To Certain Claims. Remote electronic access to the transcript is restricted until 6/1/2020. The transcript may be viewed at the Bankruptcy Court Clerks Office. [Transcription Service Agency: Veritext Legal Solutions.]. (See the Courts Website for contact information for the Transcription Service Agency.) (RE: related document(s) 426, 432). Notice of Intent to Request Redaction Deadline Due By 3/9/2020. Statement of Redaction Request Due By 3/23/2020. Redacted Transcript Submission Due By 4/2/2020. Transcript access will be restricted through 6/1/2020. (Ramos, Jonathan)Bankr. S.D.N.Y., No. 19-11632, ECF No. 440Dkt. 440
Feb 27Order Granting Debtors' Seventh Omnibus Objection to Certain Claims (Related Doc # 426) signed on 2/27/2020.Bankr. S.D.N.Y., No. 19-11632, ECF No. 435Dkt. 435
Feb 27Order of Final Decree Closing Debtors' Chapter 11 Cases (Related Doc # 432) signed on 2/27/2020. The cases of Aegerion Pharmaceuticals, Inc. (Case No. 19-11632) and Aegerion Pharmaceuticals Holdings, Inc. (Case No. 19-11633) (collectively, the Cases) are closed.Bankr. S.D.N.Y., No. 19-11632, ECF No. 436Dkt. 436
Feb 25Notice of Agenda of Matters Scheduled for Hearing on February 27, 2020 at 10:00 A.M. (Eastern Time) filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. with hearing to be held on 2/27/2020 at 10:00 AM at Courtroom 523 (MG)Bankr. S.D.N.Y., No. 19-11632, ECF No. 434Dkt. 434
Feb 10Application for Final Decree / Motion for Final Decree Closing Debtors' Chapter 11 Cases, with hearing to be held on February 27, 2020 at 10:00 a.m. (prevailing Eastern Time) filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc. Responses due by 2/20/2020,.Bankr. S.D.N.Y., No. 19-11632, ECF No. 432Dkt. 432

Full docket (438) →

Case facts and filing dates come from court records.

Case closed Feb 27, 2020

Updated Oct 3, 2:08 PM ET

Petition filed
May 20, 2019
Case closed
Feb 27, 2020

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Key firms

Willkie Farr & Gallagher LLPBankruptcy Counsel
Cassels Brock & Blackwell LLPBankruptcy Counsel
Herbert Smith Freehills KramerBankruptcy Counsel
Province, LLCFinancial Advisor
Moelis & CompanyInvestment Banker

Recent filings

Mar 3Post-Confirmation Report. / Post-Confirmation Affidavit of Disbursements for the Period January 1, 2020 through February 29, 2020 Filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc..Bankr. S.D.N.Y., No. 19-11632, ECF No. 438Dkt. 438
Mar 2Transcript regarding Hearing Held on 02/27/2020 At 10:06 AM RE: (Doc. No. 432) Motion For Final Decree Closing Debtors Chapter 11 Cases.; (Doc No. 426) Debtors Seventh Omnibus Objection To Certain Claims. Remote electronic access to the transcript is restricted until 6/1/2020. The transcript may be viewed at the Bankruptcy Court Clerks Office. [Transcription Service Agency: Veritext Legal Solutions.]. (See the Courts Website for contact information for the Transcription Service Agency.) (RE: related document(s) 426, 432). Notice of Intent to Request Redaction Deadline Due By 3/9/2020. Statement of Redaction Request Due By 3/23/2020. Redacted Transcript Submission Due By 4/2/2020. Transcript access will be restricted through 6/1/2020. (Ramos, Jonathan)Bankr. S.D.N.Y., No. 19-11632, ECF No. 440Dkt. 440
Feb 27Order Granting Debtors' Seventh Omnibus Objection to Certain Claims (Related Doc # 426) signed on 2/27/2020.Bankr. S.D.N.Y., No. 19-11632, ECF No. 435Dkt. 435
Feb 27Order of Final Decree Closing Debtors' Chapter 11 Cases (Related Doc # 432) signed on 2/27/2020. The cases of Aegerion Pharmaceuticals, Inc. (Case No. 19-11632) and Aegerion Pharmaceuticals Holdings, Inc. (Case No. 19-11633) (collectively, the Cases) are closed.Bankr. S.D.N.Y., No. 19-11632, ECF No. 436Dkt. 436
Feb 25Notice of Agenda of Matters Scheduled for Hearing on February 27, 2020 at 10:00 A.M. (Eastern Time) filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc.. with hearing to be held on 2/27/2020 at 10:00 AM at Courtroom 523 (MG)Bankr. S.D.N.Y., No. 19-11632, ECF No. 434Dkt. 434
Feb 10Application for Final Decree / Motion for Final Decree Closing Debtors' Chapter 11 Cases, with hearing to be held on February 27, 2020 at 10:00 a.m. (prevailing Eastern Time) filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals, Inc. Responses due by 2/20/2020,.Bankr. S.D.N.Y., No. 19-11632, ECF No. 432Dkt. 432

Full docket (438) →

Case facts and filing dates come from court records.